id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-263099-uhou04sp	Marlais, Matko	The severity of COVID-19 in children on immunosuppressive medication	2020-05-13		.txt	text/plain	596	41	55	1 We are currently managing an ongoing survey that includes children aged 0-19 years with kidney disease on immunosuppressive medication who are diagnosed with COVID-19. These data from a small number of children suggests that even child ren receiving immunosuppressive treatment for various indications appear to have a mild clinical course of COVID-19. Similarly, a study with eight children with inflammatory bowel disease found that all children diagnosed with COVID-19 had a mild infection, despite treatment with immunomodulators, biologics, or both. Although with a survey administered online there is a risk of underreporting because not all clinicians might receive it, we believe that the widespread dissemination of this survey across multiple international organisations would mean that most severe cases of COVID-19 in children with kidney disease would be reported. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study	./cache/cord-263099-uhou04sp.txt	./txt/cord-263099-uhou04sp.txt